By Dan Ivers ( May 22, 2014, 3:31 PM EDT) -- Two qui tam plaintiffs on Thursday freed four medical companies from a suit claiming they were involved in a kickback scheme with Amgen Inc. to market its anemia drug off-label, ending a decadelong False Claims Act dispute over the drugmaker's admitted misbranding of its Aranesp anemia drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.